LAG-3 expression is correlated with poor prognosis in renal clear cell carcinoma (RCC), low-grade glioma, uveal melanoma, hepatocellular carcinoma (HCC), head and neck squamous cell carcinoma, and non-small cell lung cancer [31–33]. This evidence concerns the gene LAG3 and glioma.